pKa determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry

This publication has 23 references indexed in Scilit:

• Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1999
• Angiotensin II receptor antagonists in hypertension
  Kidney International, 1998
• Determination of losartan and its degradates in COZAAR® tablets by reversed-phase high-performance thin-layer chromatography
  Journal of Pharmaceutical and Biomedical Analysis, 1998
• High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man
  European Journal of Clinical Pharmacology, 1997
• Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose
  Xenobiotica, 1997
• Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar® tablets
  Journal of Pharmaceutical and Biomedical Analysis, 1996
• The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs
  Archives of internal medicine (1960), 1995
• Goals of Antihypertensive Therapy
  Drugs, 1995
• Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1992